Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoietic cells

Gene Therapy
Anke WahlersChristopher Baum

Abstract

Using retroviral vectors encoding enhanced green fluorescent protein (EGFP), we addressed to what extent expression of retroviral transgenes in hematopoietic cells depends on the multiplicity of infection (MOI) and on the half-life of the encoded protein. We show that an elevation of the MOI not only elevates the frequency of transduced cells, but also increases transgene expression levels and reduces interanimal variability in vivo (hematopoietic cells of C57BL/6J mice analyzed 13 weeks after transplantation). This suggests that the MOI has to be carefully controlled and should be adapted as desired for clinical studies when evaluating vector performance in preclinical models. The impact of protein stability is demonstrated by comparing vectors expressing EGFP or a destabilized variant with a C-terminal PEST-sequence, d2EGFP. The loss of expression with d2EGFP was more pronounced in terminally differentiated cells of the peripheral blood (>30 fold) than in progenitor cells (five- to 10-fold), indicating a stronger transcription of the retroviral promoter in progenitor cells and a predominant role of protein inheritance over de novo synthesis of transgenic protein in mature blood cells. This analysis reveals an important and di...Continue Reading

References

Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·I RivièreR C Mulligan
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K AndoJ D Griffin
Aug 1, 1996·Human Gene Therapy·T M Kinsella, G P Nolan
Aug 1, 1997·Molecular Medicine Today·R MazeD A Williams
Nov 1, 1996·Current Opinion in Hematology·C E Dunbar, N S Young
Dec 18, 1998·The Journal of Biological Chemistry·X LiS R Kain
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·S S CaseG M Crooks
Sep 28, 1999·Molecular Medicine Today·R A Morgan
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·S BarretteD M Bodine
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·B FehseC Baum
Oct 25, 2000·Human Gene Therapy·D A Williams, F O Smith

❮ Previous
Next ❯

Citations

Feb 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·John RamunasEric J Jervis
Aug 12, 2003·Human Gene Therapy·Boris EngelsWolfgang Uckert
Jun 10, 2004·Stem Cells and Development·Sonja LogesUrsula M Gehling
Mar 21, 2006·Human Gene Therapy·Christopher BaumBoris Fehse
May 25, 2007·Stem Cells and Development·Claudia LangeBoris Fehse
Apr 23, 2010·Journal of Virology·Julia D SuerthAxel Schambach
Nov 26, 2010·BMC Biotechnology·Rainer LoewManfred Gossen
Sep 8, 2015·Journal of Clinical Medicine·Fangmei AnFlorin M Selaru
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Alexander CarpinteiroSusanna Hegewisch-Becker
Sep 1, 2009·Biotechnology and Bioengineering·Venkata S TayiJames M Piret
Nov 3, 2005·Experimental Hematology·Hayrettin GuvenM Sirac Dilber
Oct 30, 2016·Cancers·Victor M Bii, Grant D Trobridge
Oct 18, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Axel SchambachChristopher Baum
Jun 15, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Peter KurreHans-Peter Kiem
Apr 25, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Christopher BaumMelanie Galla
Jul 3, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Marcus StockschlaederRuediger E Scharf
Aug 3, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Alexandru V OlaruFlorin M Selaru
Jan 4, 2003·Blood·Christopher BaumChristof von Kalle
May 26, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tsukasa OhmoriYoichi Sakata
May 22, 2019·Cells·Stefan StoiberSebastian Kobold

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.